Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.21.2
Condensed Balance Sheets - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Assets    
Current asset - Cash $ 729,607 $ 35,614
Prepaid expenses 292,500  
Deferred offering costs   469,160
Total current assets 1,022,107 504,774
Prepaid expenses, non-current 206,404  
Cash and securities held in Trust Account 276,040,259  
Total Assets 277,268,770 504,774
Current liabilities:    
Accrued offering costs and expenses 11,350 330,300
Due to related party 18,986  
Promissory note - related party 150,000 150,000
Total current liabilities 180,336 480,300
Deferred underwriting discount 9,660,000  
Total liabilities 9,840,336 480,300
Commitments
Common Stock subject to possible redemption, 26,242,843 and 0 shares at redemption value, respectively 262,428,430  
Stockholders’ Equity:    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Common stock, $0.0001 par value; 100,000,000 shares authorized; 8,257,157 and 6,900,000 shares issued and outstanding (excluding 26,242,843 and 0 shares subject to possible redemption, respectively) 826 690
Additional paid-in capital 5,049,658 24,310
Accumulated deficit (50,480) (526)
Total Stockholders’ equity 5,000,004 24,474
Total Liabilities and Stockholders’ Equity $ 277,268,770 $ 504,774